EMJ Diabetes最新文献_第3页

Update on the Guidelines of Obesity Management 肥胖管理指南的最新进展

EMJ Diabetes Pub Date : 2022-05-25 DOI: 10.33590/emjdiabet/22e0601

Janet Nzisa

引用次数: 0

Diabetic Ketoacidosis Precipitated by COVID-19: A Case Report 新冠肺炎诱发糖尿病酮症酸中毒1例

EMJ Diabetes Pub Date : 2022-05-16 DOI: 10.33590/emj/21-00125

P. Paramanathan, Muhammad Abbas

{"title":"Diabetic Ketoacidosis Precipitated by COVID-19: A Case Report","authors":"P. Paramanathan, Muhammad Abbas","doi":"10.33590/emj/21-00125","DOIUrl":"https://doi.org/10.33590/emj/21-00125","url":null,"abstract":"Introduction: Diabetic emergencies such as diabetic ketoacidosis (DKA) are life-threatening complications, often precipitated by infections or illnesses such as COVID-19. \u0000\u0000Case presentation: A 55-year-old African American female presented to their primary care physician, complaining of fatigue, dehydration, decreased appetite, hypersomnia, and sudden weight loss, and a past medical history of Type 2 diabetes. They had a glucose level of >15 mmol/L and ketone level of >16 mmol/L; they were immediately sent to the emergency department for assessment of DKA. There, the patient tested positive for COVID-19. They had a glucose level of 361 mg/dL, a pH of 7.11, a bicarbonate level of 10 mEq/L, a sodium level of 125 mEq/L, a potassium level of 3.9 mEq/L, a chloride level of 95 mEq/L, an anion gap of 20, and a positive ketone level. Over the next few days, the patient’s condition got worse; their chest CT scan showed ground-glass opacities with consolidations in the middle and inferior lobes of the lungs bilaterally, along with interlobular septal thickening, which are consistent with an atypical infection, respiratory distress, and pneumonia. The patient was on intravenous fluids, insulin therapy and empirical antibiotics for the next few weeks, and eventually recovered. \u0000\u0000Discussion: Factors precipitating DKA in patients with diabetes in the setting of COVID-19are: the increased secretions of stress hormones that counter the effects of insulin and increase blood glucose levels, and the ways in which severe acute respiratory syndrome coronavirus 2 interacts with human cells, leading to pancreatic islet cell damage. \u0000\u0000Conclusion: Diabetes and COVID-19 intensify each other’s complications in patients diagnosed with both.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130709301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Acute Worsening of Glycaemic Control in a Patient with Latent Autoimmune Diabetes of Adulthood After Receiving the COVID-19 Vaccine 1例成人潜伏性自身免疫性糖尿病患者接种COVID-19疫苗后血糖控制急性恶化

EMJ Diabetes Pub Date : 2022-05-09 DOI: 10.33590/emjdiabet/21-00263

Nicole J Altomare, David A. Cohen

引用次数: 1

Academy™: An Online Diabetes Educational Programme for Healthcare Professionals 学院™:为医疗保健专业人员提供的在线糖尿病教育计划

EMJ Diabetes Pub Date : 2022-05-04 DOI: 10.33590/emj/22c0070

Jennifer Taylor

引用次数: 0

Chronic Complications of Diabetes 糖尿病的慢性并发症

EMJ Diabetes Pub Date : 2022-04-25 DOI: 10.33590/emjdiabet/21-00180

Lisa C Martinez, Touqir Zahra

引用次数: 0

Comorbidity of Anxiety and Depression with Hypertension, Diabetes, and Cardiovascular Disease: A Selective Systematic Review from India 焦虑和抑郁与高血压、糖尿病和心血管疾病的共病:一项来自印度的选择性系统综述

EMJ Diabetes Pub Date : 2022-03-14 DOI: 10.33590/emjdiabet/21-00189

Sukanya Rajan, Archith Krishna, K. Muliyala, S. Chaturvedi

{"title":"Comorbidity of Anxiety and Depression with Hypertension, Diabetes, and Cardiovascular Disease: A Selective Systematic Review from India","authors":"Sukanya Rajan, Archith Krishna, K. Muliyala, S. Chaturvedi","doi":"10.33590/emjdiabet/21-00189","DOIUrl":"https://doi.org/10.33590/emjdiabet/21-00189","url":null,"abstract":"Context: Non-communicable diseases (cardiovascular diseases, hypertension, and diabetes) and comorbid common mental disorders are of public health concern because of their high morbidity and mortality rates. The authors undertook a systematic review of studies that reported the prevalence of common mental disorders among non-communicable diseases, specifically in India. \u0000\u0000Evidence acquisition: Relevant databases (Medline, Google Scholar, EBSCO, and ProQuest) were searched until May 2021. Descriptive and observation studies from the mentioned databases were included. \u0000\u0000Evidence synthesis: Of the total 6,515 studies, the electronic literature search identified 4,307 studies. Manual cross-referencing identified an additional 2,208 studies. Only 17 studies met the criteria and were included for the review. \u0000\u0000Findings: Twelves studies focused on the prevalence of anxiety and depression in patients with diabetes, three studies focused on cardiovascular disease, two on non-communicable diseases, and one on the prevalence of depression in hypertension. The range of the prevalence of anxiety disorder and depression was 3.9–44% and 8–44%, respectively. \u0000\u0000Conclusion: High prevalence of anxiety and depression is seen in people with diabetes, indicating these are of serious public health concerns in India.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"700 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132814832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Disorders of Gastrointestinal Motility in Diabetes Mellitus: An Unattended Borderline Between Diabetologists and Gastroenterologists 糖尿病患者胃肠运动障碍:糖尿病学家和胃肠病学家之间无人关注的界线

EMJ Diabetes Pub Date : 2021-11-09 DOI: 10.33590/emjdiabet/21-00155

P. Pal, Subhodip Pramanik, S. Ray

{"title":"Disorders of Gastrointestinal Motility in Diabetes Mellitus: An Unattended Borderline Between Diabetologists and Gastroenterologists","authors":"P. Pal, Subhodip Pramanik, S. Ray","doi":"10.33590/emjdiabet/21-00155","DOIUrl":"https://doi.org/10.33590/emjdiabet/21-00155","url":null,"abstract":"Gastrointestinal (GI) symptoms represent an important and often poorly appreciated reason of morbidity in diabetes mellitus. Diabetes can affect nearly all parts of the GI tract; however, data on the prevalence of ‘diabetic gastroenteropathy’ are inconsistent. The significance of disturbed GI motility in diabetes across the patient spectrum and pathophysiological basis also remain inadequately defined. Fluctuating glucose levels, altered drug pharmacokinetics, variable absorption of nutrients, and impaired quality of life are important consequences of GI dysfunction. Diabetic gastroparesis is the best characterised manifestation of GI motility disorder in diabetes. Since there is a poor correlation between subjective GI symptoms and objective motility findings, a diagnosis of delayed emptying in diabetes requires a proper measurement of gastric emptying. There are fewer studies on intestinal motility in diabetes than those on the stomach. Several established modalities exist for the assessment of gastroenteropathy but the lack of standardisation, exposure to radiation, advanced data interpretation, and high cost limit their widespread use. While existing therapeutic choices for the management of diabetic gastroenteropathy are suboptimal, many potential novel agents are in progress. Both endocrinology and gastroenterology specialties working together will facilitate screening and treating patients with diabetes and GI dysmotility.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114946982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance? 糖尿病患者卒中:是时候扩大公共卫生优先考虑胰岛素抵抗增加的高危患者了吗?

EMJ Diabetes Pub Date : 2021-11-09 DOI: 10.33590/emjdiabet/21-00171

Siân Bradley, Francis Muttamthottil Varghese, B. Menon, M. Mehndiratta, S. Bhaskar

引用次数: 2

How to Manage Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Let’s Hear the Patient’s Voice COVID-19大流行期间如何管理2型糖尿病:让我们倾听患者的声音

EMJ Diabetes Pub Date : 2021-11-09 DOI: 10.33590/emjdiabet/21-00133

Joanne Lusher, D. Cameron

引用次数: 0

Socio-demographic Determinants of Attendance in Diabetes Education Centres: A Survey of Patients’ Views 糖尿病教育中心出勤的社会人口学决定因素:一项患者观点调查

EMJ Diabetes Pub Date : 2021-11-09 DOI: 10.33590/emjdiabet/21-00079

M. Lawal, A. Woodman

引用次数: 2